ImmunityBio has established a wholly owned subsidiary in Saudi Arabia, to support its distribution, commercialization, and growth across the Middle East and North Africa. Lung cancer is among the most prevalent cancers in Saudi Arabia and is the third most common cancer among males over 45 years of age, according to the Saudi Ministry of Health1. Established in 1987, Cigalah Healthcare is the fastest growing health care distributor in Saudi Arabia and the Middle East. About Biopharma Middle East and Africa:Biopharma-mea is a regional Middle East company, headquartered in Dubai, United Arab Emirates, with offices across the Middle East countries. References:Saudi national lung cancer epidemiology from the Saudi Cancer Registry, 2015–2020 (AlOmar & AlAbdulKader, J Epidemiol Glob Health, 2025).

Source: The North Africa Journal February 21, 2026 04:35 UTC